![Logo for Exscientia plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F1e4e8-2023-12-27-07-42-00.png&w=256&q=100)
Exscientia Investor Relations Material
Latest events
![Logo for Exscientia plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F1e4e8-2023-12-27-07-42-00.png&w=128&q=100)
Q1 2024
Exscientia
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Exscientia plc
Access all reports
Exscientia plc is a pharmatech company leveraging artificial intelligence (AI) in the discovery, design, and development of drugs. The company employs a patient-first AI approach across various stages of drug development, including precision target identification, design, experimentation, and medicine optimization. It aims to accelerate the process of bringing new, effective treatments to patients with a focus on precision oncology and a broader range of therapeutic areas through partnered pipelines. The company is headquartered in Oxford, United Kingdom, and its shares are listed on the Nasdaq.
Key slides for Exscientia plc
![Exscientia's pharma](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fexscientia-plc-q1-2024-f49e2e4026484005%2F14.png&w=3840&q=75)
![Logo for Exscientia plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F1e4e8-2023-12-27-07-42-00.png&w=128&q=100)
Q1 2024
Exscientia plc
![ELUCIDATE : ' 617 Ph](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fexscientia-plc-corporate-presentation-47a5b590da7e931b%2F47.png&w=3840&q=75)
![Logo for Exscientia plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F1e4e8-2023-12-27-07-42-00.png&w=128&q=100)
Corporate Presentation
Exscientia plc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
EXAI
Country
🇺🇸 United States